Adil Maarouf

1.6k total citations
51 papers, 811 citations indexed

About

Adil Maarouf is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Adil Maarouf has authored 51 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 20 papers in Neurology and 12 papers in Oncology. Recurrent topics in Adil Maarouf's work include Multiple Sclerosis Research Studies (33 papers), Peripheral Neuropathies and Disorders (12 papers) and Polyomavirus and related diseases (11 papers). Adil Maarouf is often cited by papers focused on Multiple Sclerosis Research Studies (33 papers), Peripheral Neuropathies and Disorders (12 papers) and Polyomavirus and related diseases (11 papers). Adil Maarouf collaborates with scholars based in France, Germany and United States. Adil Maarouf's co-authors include Bertrand Audoin, Jean Pelletier, Audrey Rico, Jean‐Philippe Ranjeva, Clémence Boutière, Maxime Guye, Wafaa Zaaraoui, Sylviane Confort‐Gouny, Ayman Tourbah and Romain Marignier and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Adil Maarouf

50 papers receiving 805 citations

Peers

Adil Maarouf
Eva Strijbis Netherlands
Channa Kolb United States
Zhaleh Khaleeli United Kingdom
Revere P. Kinkel United States
Adil Maarouf
Citations per year, relative to Adil Maarouf Adil Maarouf (= 1×) peers Philipp Eisele

Countries citing papers authored by Adil Maarouf

Since Specialization
Citations

This map shows the geographic impact of Adil Maarouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adil Maarouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adil Maarouf more than expected).

Fields of papers citing papers by Adil Maarouf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adil Maarouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adil Maarouf. The network helps show where Adil Maarouf may publish in the future.

Co-authorship network of co-authors of Adil Maarouf

This figure shows the co-authorship network connecting the top 25 collaborators of Adil Maarouf. A scholar is included among the top collaborators of Adil Maarouf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adil Maarouf. Adil Maarouf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boutière, Clémence, Audrey Rico, Jan‐Patrick Stellmann, et al.. (2025). Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome. Neurology Neuroimmunology & Neuroinflammation. 12(2). e200379–e200379. 1 indexed citations
2.
Boutière, Clémence, Audrey Rico, Jan‐Patrick Stellmann, et al.. (2025). Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis. Neurology Neuroimmunology & Neuroinflammation. 12(3). e200386–e200386. 1 indexed citations
3.
Lépine, Anne, Adil Maarouf, Damien Biotti, et al.. (2024). Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis. Multiple Sclerosis Journal. 30(2). 261–265. 9 indexed citations
4.
Maarouf, Adil, Audrey Rico, Clémence Boutière, et al.. (2024). Active and non-active progression independent of relapse activity within the first 20 years of relapsing multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 95(10). jnnp–2024. 1 indexed citations
5.
Maarouf, Adil, Clémence Boutière, Audrey Rico, et al.. (2024). Factors affecting the topography of nitrous oxide‐induced neurological complications. European Journal of Neurology. 31(7). e16291–e16291. 3 indexed citations
6.
Boutière, Clémence, Audrey Rico, Frédéric Vely, et al.. (2024). Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200231–e200231. 2 indexed citations
7.
Joubert, Bastien, Marie Bénaiteau, Clémence Boutière, et al.. (2024). Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis. Neurology. 102(8). e209284–e209284. 1 indexed citations
8.
Maarouf, Adil, et al.. (2023). Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception. Neurology Neuroimmunology & Neuroinflammation. 10(5). 5 indexed citations
9.
Rico, Audrey, Clémence Boutière, Frédéric Vely, et al.. (2023). Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 22 indexed citations
10.
Maarouf, Adil, Bertrand Audoin, Mohamed Mounir El Mendili, et al.. (2022). Grey-matter sodium concentration as an individual marker of multiple sclerosis severity. Multiple Sclerosis Journal. 28(12). 1903–1912. 3 indexed citations
11.
Pique, Julie, Adil Maarouf, Xavier Ayrignac, et al.. (2022). Time to steroids impacts visual outcome of optic neuritis in MOGAD. Journal of Neurology Neurosurgery & Psychiatry. 94(4). 309–313. 18 indexed citations
12.
Rico, Audrey, Läétitia Ninove, Adil Maarouf, et al.. (2021). Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(4). 3080425342–3080425342. 5 indexed citations
13.
Maillart, Élisabeth, Pierre Labauge, Mikaël Cohen, et al.. (2021). MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 55. 103164–103164. 8 indexed citations
14.
Stellmann, Jan‐Patrick, Adil Maarouf, Susanne Gellißen, et al.. (2021). Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis. NeuroImage Clinical. 30. 102606–102606. 13 indexed citations
15.
Grapperon, Aude‐Marie, Ben Ridley, Annie Verschueren, et al.. (2019). Quantitative Brain Sodium MRI Depicts Corticospinal Impairment in Amyotrophic Lateral Sclerosis. Radiology. 292(2). 422–428. 24 indexed citations
16.
Maarouf, Adil, Delphine Stephan, Jean‐Philippe Ranjeva, et al.. (2019). High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis. Journal of Translational Medicine. 17(1). 51–51. 13 indexed citations
17.
Ridley, Ben, Armin M. Nagel, Mark Bydder, et al.. (2018). Distribution of brain sodium long and short relaxation times and concentrations: a multi-echo ultra-high field 23Na MRI study. Scientific Reports. 8(1). 4357–4357. 41 indexed citations
18.
Maarouf, Adil, Clémence Boutière, Audrey Rico, Bertrand Audoin, & Jean Pelletier. (2018). How much progress has there been in the second-line treatment of multiple sclerosis: A 2017 update. Revue Neurologique. 174(6). 429–440. 6 indexed citations
19.
Reuter, Françoise, Wafaa Zaaraoui, Arnaud Le Troter, et al.. (2017). New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study. PLoS ONE. 12(11). e0184650–e0184650. 19 indexed citations
20.
Commowick, Olivier, Adil Maarouf, Jean‐Christophe Ferré, et al.. (2015). Diffusion MRI abnormalities detection with orientation distribution functions: A multiple sclerosis longitudinal study. Medical Image Analysis. 22(1). 114–123. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026